Journal ArticleDOI
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
Joseph E. Schwartz,Jeffrey L. Winters,Anand Padmanabhan,Rasheed A. Balogun,Meghan Delaney,Michael L. Linenberger,Zbigniew M. Szczepiorkowski,Mark E. Williams,Yanyun Wu,Beth H. Shaz +9 more
TLDR
The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.Abstract:
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the Committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Seventh Edition of the JCA Special Issue continues to maintain this methodology and rigor to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Seventh Edition, like its predecessor, has consistently applied the category and grading system definitions in the fact sheets. The general layout and concept of a fact sheet that was used since the fourth edition has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis in a specific disease entity. The Seventh Edition discusses 87 fact sheets (14 new fact sheets since the Sixth Edition) for therapeutic apheresis diseases and medical conditions, with 179 indications, which are separately graded and categorized within the listed fact sheets. Several diseases that are Category IV which have been described in detail in previous editions and do not have significant new evidence since the last publication are summarized in a separate table. The Seventh Edition of the JCA Special Issue serves as a key resource that guides the utilization of therapeutic apheresis in the treatment of human disease. J. Clin. Apheresis 31:149-162, 2016. © 2016 Wiley Periodicals, Inc.read more
Citations
More filters
Journal ArticleDOI
American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock.
Alan L. Davis,Joseph A. Carcillo,Rajesh K. Aneja,Andreas J. Deymann,John C. Lin,Trung C. Nguyen,Regina Okhuysen-Cawley,Monica S. Relvas,Ranna A. Rozenfeld,Peter Skippen,Bonnie J. Stojadinovic,Eric A. Williams,Tim S. Yeh,Fran Balamuth,Joe Brierley,Allan R. de Caen,Ira M. Cheifetz,Karen Choong,Edward E. Conway,Timothy T. Cornell,Allan Doctor,Marc Andre Dugas,Jonathan D. Feldman,Julie C. Fitzgerald,Heidi R. Flori,James D. Fortenberry,Ana Lia Graciano,Bruce M. Greenwald,Mark W. Hall,Yong Yun Han,Lynn J. Hernan,Jose Irazuzta,Elizabeth Iselin,Elise W. van der Jagt,Howard E. Jeffries,Saraswati Kache,Chhavi Katyal,Niranjan Kissoon,Alexander A. Kon,Martha C. Kutko,Graeme MacLaren,Graeme MacLaren,Timothy M. Maul,Renuka Mehta,Fola Odetola,Kristine A Parbuoni,Raina Paul,Mark J. Peters,Suchitra Ranjit,Karin Reuter-Rice,Eduardo Schnitzler,Halden F. Scott,Adalberto Torres,Jacki Weingarten-Abrams,Scott L. Weiss,Jerry J. Zimmerman,Aaron L. Zuckerberg +56 more
TL;DR: A major new recommendation in the 2014 update of the 2007 American College of Critical Care Medicine “Clinical Guidelines for Hemodynamic Support of Neonates and Children with Septic Shock” is consideration of institution—specific use of a recognition bundle containing a trigger tool for rapid identification of patients with septic shock.
Journal ArticleDOI
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Brad H. Rovin,Sharon G. Adler,Jonathan Barratt,Frank Bridoux,Kelly A. Burdge,Tak Mao Chan,H. Terence Cook,Fernando C. Fervenza,Keisha L. Gibson,Richard J. Glassock,David Jayne,Vivekanand Jha,Adrian Liew,Zhihong Liu,Juan M. Mejia-Vilet,Carla M. Nester,Jai Radhakrishnan,Elizabeth M. Rave,Heather N. Reich,Pierre Ronco,Jan-Stephan F. Sanders,Sanjeev Sethi,Yusuke Suzuki,Sydney C.W. Tang,Vladimir Tesar,Marina Vivarelli,Jack F.M. Wetzels,Jürgen Floege +27 more
Journal ArticleDOI
Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel.
Hartmut Döhner,Andrew H. Wei,Frederick R. Appelbaum,Charles Craddock,Courtney D. DiNardo,Hervé Dombret,Benjamin L. Ebert,Pierre Fenaux,Lucy A. Godley,Robert P. Hasserjian,Richard A. Larson,Ross Levine,Yasushi Miyazaki,Dietger Niederwieser,Gert J. Ossenkoppele,Christoph Röllig,Jorge Sierra,Eytan M. Stein,Martin S. Tallman,Hwei-Fang Tien,Jianxiang Wang,Agnieszka Wierzbowska,Bob Löwenberg +22 more
TL;DR: This update includes a revised ELN genetic risk classification, revised response criteria, and treatment recommendations for acute myeloid leukemia in adults, which are widely recognized among physicians and investigators.
Journal ArticleDOI
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Michael Walsh,Peter A. Merkel,Chen-Au Peh,Wladimir Szpirt,Xavier Puéchal,Shouichi Fujimoto,Carmel M. Hawley,Nader Khalidi,Oliver Floßmann,Ron Wald,Louis Girard,Adeera Levin,Gina Gregorini,Lorraine Harper,William F. Clark,Christian Pagnoux,Ulrich Specks,Lucy Smyth,Vladimir Tesar,Toshiko Ito-Ihara,Toshiko Ito-Ihara,Janak de Zoysa,Wojciech Szczeklik,Luis Felipe Flores-Suárez,Simon Carette,L. Guillevin,Charles D. Pusey,Alina Casian,Biljana Brezina,Andrea Mazzetti,Carol A. McAlear,Elizabeth Broadhurst,Donna Reidlinger,Samir Mehta,Natalie Ives,David Jayne,Pexivas Investigators Pexivas Investigators +36 more
TL;DR: Among patients with severe ANCA-associated vasculitis, the use of plasma exchange did not reduce the incidence of death or ESKD, and a reduced-dose regimen of glucocorticoids was noninferior to a standard- dose regimen with respect to death orESKD.
References
More filters
Journal ArticleDOI
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis
Tomoko Henzan,Koji Nagafuji,Hiroshi Tsukamoto,Toshihiro Miyamoto,Hisashi Gondo,Shinsaku Imashuku,Mine Harada +6 more
TL;DR: For HLH patients not responding to conventional therapy, anticytokine treatment with infliximab may represent one of promising options.
Journal ArticleDOI
Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients.
TL;DR: The improvement seen in patients with active disease suggests that plasmapheresis with immunosuppressive drug therapy may find a place in their treatment and implicates circulating factors in the pathogenesis of IM.
Journal ArticleDOI
Toxic epidermal necrolysis (Lyell's disease).
TL;DR: Different authors reported good results in terms of decreasing mortality and morbidity or improving clinical conditions of the use of human intravenous immunoglobulins (IVIGs).
Journal ArticleDOI
Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange
TL;DR: A patient with severe heredopathia atactica polyneuritiformis (Refsum's disease) has responded well to treatment by large-volume plasma-exchange and the dietary control of the disease has been shown to depend on a diet high in calories, which prevents mobilisation of phytanic acid from fat stores.
Journal ArticleDOI
Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis.
Divya S. Khurana,Joseph J. Melvin,Sanjeev V. Kothare,Ignacio Valencia,H. Huntley Hardison,Sabrina W. Yum,Eric N. Faerber,Agustin Legido +7 more
TL;DR: Presentation of ADEM with delayed development of MRI lesions in deep gray matter and brainstem may herald a prolonged clinical course and lack of response to glucocorticoid therapy.